BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 1901144)

  • 21. [Otoacoustic distortion products in sensorineural hearing loss in the cochlea].
    Ricci G; Molini E; Fantera A; Manna V; Simoncelli C
    Acta Otorhinolaryngol Ital; 1996 Dec; 16(6):492-500. PubMed ID: 9381918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Middle Ear Muscle Reflex and Word Recognition in "Normal-Hearing" Adults: Evidence for Cochlear Synaptopathy?
    Mepani AM; Kirk SA; Hancock KE; Bennett K; de Gruttola V; Liberman MC; Maison SF
    Ear Hear; 2020; 41(1):25-38. PubMed ID: 31584501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determining the cause of hearing loss: differential diagnosis using a comparison of audiometric and otoacoustic emission responses.
    Mills DM
    Ear Hear; 2006 Oct; 27(5):508-25. PubMed ID: 16957501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identifying three otopathologies in humans.
    Parker MA
    Hear Res; 2020 Dec; 398():108079. PubMed ID: 33011456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of glycerol test in Meniere's disease with pure tone audiometry and distortion product otoacoustic emission].
    Jabłonka A; Pośpiech L; Orendorz-Fraczkowska K
    Otolaryngol Pol; 2003; 57(5):731-7. PubMed ID: 14994621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD1 hearing-impaired mice. I: Distortion product otoacoustic emission levels, cochlear function and morphology.
    Le Calvez S; Avan P; Gilain L; Romand R
    Hear Res; 1998 Jun; 120(1-2):37-50. PubMed ID: 9667429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Unusual electrocochleography cases].
    Marangos N; Laszig R; Mausolf A
    HNO; 1989 Sep; 37(9):379-85. PubMed ID: 2808013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two-source interference as the major reason for auditory-threshold estimation error based on DPOAE input-output functions in normal-hearing subjects.
    Dalhoff E; Turcanu D; Vetešník A; Gummer AW
    Hear Res; 2013 Feb; 296():67-82. PubMed ID: 23268357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of hearing loss in acoustic neuroma: an otoacoustic emission study.
    Prasher DK; Tun T; Brookes GB; Luxon LM
    Acta Otolaryngol; 1995 May; 115(3):375-81. PubMed ID: 7653257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Neuro-otologic criteria in the diagnosis of tumor-induced hearing disorders. Studies of 300 patients with acoustic neuroma].
    Mausolf A; Laubert A
    HNO; 1990 Feb; 38(2):50-5. PubMed ID: 2318668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distortion product otoacoustic emissions: hit and false-positive rates in normal-hearing and hearing-impaired subjects.
    Musiek FE; Baran JA
    Am J Otol; 1997 Jul; 18(4):454-61. PubMed ID: 9233485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of cochlear synaptopathy on middle-ear muscle reflexes in unanesthetized mice.
    Valero MD; Hancock KE; Maison SF; Liberman MC
    Hear Res; 2018 Jun; 363():109-118. PubMed ID: 29598837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distortion-product otoacoustic emission spectra and high-resolution audiometry in noise-induced hearing loss.
    Avan P; Bonfils P
    Hear Res; 2005 Nov; 209(1-2):68-75. PubMed ID: 16112827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns of evoked otoacoustic emissions associated with acoustic neuromas.
    Telischi FF; Roth J; Stagner BB; Lonsbury-Martin BL; Balkany TJ
    Laryngoscope; 1995 Jul; 105(7 Pt 1):675-82. PubMed ID: 7603269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GFAP aggregates in the cochlear nerve increase the noise vulnerability of sensory cells in the organ of Corti in the murine model of Alexander disease.
    Masuda M; Tanaka KF; Kanzaki S; Wakabayashi K; Oishi N; Suzuki T; Ikenaka K; Ogawa K
    Neurosci Res; 2008 Sep; 62(1):15-24. PubMed ID: 18602179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical utility of distortion-product otoacoustic emissions.
    Lonsbury-Martin BL; Martin GK
    Ear Hear; 1990 Apr; 11(2):144-54. PubMed ID: 2187725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency analysis of transiently evoked otoacoustic emissions in sensorineural hearing disturbance.
    Fuse T; Aoyagi M; Suzuki Y; Koike Y
    Acta Otolaryngol Suppl; 1994; 511():91-4. PubMed ID: 8203251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical application of transiently evoked otoacoustic emissions after glycerol administration for diagnosis of sensorineural hearing loss.
    Inoue Y; Kanzaki J; O-Uchi T; Ogawa K; Ogata A; Yoshihara S; Satoh Y
    Auris Nasus Larynx; 1997 Apr; 24(2):143-9. PubMed ID: 9134136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Auditory threshold evaluation by distortion-product oto-acoustic emissions using decision support system.
    Bonfils P; Avan P; Elbez M; Deys S; Erminy M; François M
    Acta Otolaryngol; 1994 Jul; 114(4):360-5. PubMed ID: 7976306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of glycine receptors containing the α3 subunit compromises auditory nerve activity, but not outer hair cell function.
    Dlugaiczyk J; Hecker D; Neubert C; Buerbank S; Campanelli D; Becker CM; Betz H; Knipper M; Rüttiger L; Schick B
    Hear Res; 2016 Jul; 337():25-34. PubMed ID: 27208792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.